Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA may take steps to ban red food dye
Red food dye could soon be banned as FDA reviews petition: ‘Scary stuff’
The U.S. Food and Drug Administration is considering banning an artificial food coloring called Red No. 3 due to potential health risks, including a link to cancer.
Will the FDA ban red dye 3? Controversial food additive used in candy, drinks under scrutiny
While the FDA has claimed that red 3, like other additives the agency has approved, can be safe to consume, advocates have long called for its ban amid concerns that the food dye is linked to cancer and behavioral problems in children.
FDA to consider banning red food dye — an ingredient not allowed in skin products yet ‘a kid can eat it’
The U.S. Food and Drug Administration (FDA) may enact a total ban on red food dye, the artificial coloring that’s not allowed in skin products but “a kid can eat it.” On December 5, the FDA gathered for a health committee meeting with the U.S. Senate to discuss a petition regarding Red No. 3, otherwise referred to as Erythrosine.
FDA Recalls Duloxetine Antidepressant for Cancer Risk
Antidepressant Recall Update As FDA Sets Risk Level
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
FDA Recalls Duloxetine Antidepressant for Cancer Risk: What to Know
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic pain. A recent Food and Drug Administration (FDA) recall of a commonly prescribed antidepressant,
Antidepressant Duloxetine recalled in the US over cancer risk concerns
Rising Pharmaceuticals has voluntarily recalled over 233,000 bottles of Duloxetine in the US due to potential contamination with N-nitroso-duloxetine, a probable carcinogen. The FDA classified the recall as Class II,
BioPharma Dive
3d
With conflicts of interest in focus, Trump’s pick to run FDA could face scrutiny of his own industry ties
A Johns Hopkins surgeon, Marty Makary also serves as a board member or adviser to several companies, including one that ...
Opinion
4h
Opinion
Regular regulation: Agencies like the EPA and FDA do more than the public sees
This week, the Environmental Protection Agency moved to largely ban the use of trichloroethylene and tetrachloroethylene, ...
2d
on MSN
FDA may outlaw food dyes ‘within weeks’: Bombshell move would affect candy, soda and cakes, revolutionize American diets
The Food and Drug Administration will decide on a ban of certain food dyes after receiving a petition to review their safety.
Sierra Sun Times
23h
FDA Says Skip the Antibacterial Soap; Use Plain Soap and Water
According to the U.S. Food and Drug Administration, there isn’t evidence to show that over-the-counter (OTC) antibacterial ...
20h
How the FDA allows companies to add secret ingredients to food
It's a U.S. Food and Drug Administration rule that most Americans know little about, yet gives corporations the license to ...
20h
FDA Approves First Fatty Liver Disease Drug: Who It’s For and How It Works
For those dealing with fatty liver disease, there’s welcome news to report. Earlier this year, the United States Food and ...
18h
FDA adds 2 more toxic products to large supplement recall: What you need to know
The Food and Drug Administration has expanded its recall of supplements that contain a dangerous toxin that can be fatal.
BioSpace
1d
FDA Action Alert: Ionis, Lexicon, AstraZeneca/Daiichi Sankyo and More
Ionis Pharmaceuticals is advancing the investigational RNA-targeted therapy olezarsen for the treatment of familial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Trump
red dye
Supreme Court of the United States
Elon Musk
Feedback